RNS Number : 8223M iShares III PLC 17 July 2026  

RNS ANNOUNCEMENT

iShares III plc (the "Company")

iShares MSCI World Small Cap UCITS ETF (the "Fund") - ISIN: IE00BF4RFH31

17 July 2026

The Directors of the Company wish to advise of a change to the securities lending limits for the Fund, as detailed below.

Current

New

Expected Net Asset Value subject to securities lending (%)

0 - 24%

0 - 30%

Maximum Net Asset Value subject to securities lending (%)

26%

33%

These changes are due to take effect on or around 31 July 2026 (the "Effective Date").

A new version of the Company's prospectus will be published on or around the Effective Date.

An electronic copy of the full shareholder letter shall be made available shortly for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism and available to download from the iShares website www.ishares.com

We understand that investors may have questions in relation to this event. If you have any queries, but you do not have a usual iShares contact, you can contact iShares in your respective region on the below contact numbers and email addresses:

•           If located in the United Kingdom or if located elsewhere than the below, you can contact iShares at: [email protected], or the helpline telephone number: +44 207 743 1500

•           If located in Germany, you can contact iShares at: [email protected], or the helpline telephone number: +49 89 42729 5858

•           If located in Switzerland, you can contact iShares at: [email protected], or the helpline telephone number 0800 33 66 88

-END-

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.  END  MSCAKOBNFBKKAOD